Production of two Excedrin painkillers halted

Production of two excedrin painkillers halted

Production and distribution of Excedrin Extra Strength and Excedrin Migraine products have been temporarily stopped, maker GlaxoSmithKline said Tuesday.

"Through routine quality control and assurance measures, we discovered inconsistencies in how we transfer and weigh for Excedrin Extra Strength Caplets and Geltabs, and Excedrin Migraine Caplets and Geltabs," the company said in a statement to CNN.

"We are working hard to resolve the issue as quickly as possible, but at this point in time cannot confirm a definite date as to when supply will resume," the company said.

"Other Excedrin products are available along with other pain-relieving drugs, but dosages may differ. Consumers should consult their pharmacist for the most suitable alternative product," GlaxoSmithKline advised.


Explore further

California considers declaring common pain killer carcinogen

More information: CNN Article

Copyright © 2020 HealthDay. All rights reserved.

Citation: Production of two Excedrin painkillers halted (2020, January 23) retrieved 29 November 2020 from https://medicalxpress.com/news/2020-01-production-excedrin-painkillers-halted.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments